In this episode, Christine VanTimmeren and Dr. Brandon Mancini are joined by Afton DeVos, Consulting Director of the Foundation for Medical Advancement and Breakthroughs (FMAB).

This conversation explores the origin and mission of FMAB—created in response to grateful patients who wanted to help others access life-saving care. Together, they discuss how the foundation is working to remove financial barriers, accelerate research, and expand education so more patients can benefit from cutting-edge therapies.

Afton shares her deeply personal connection to this work as a cancer survivor and caregiver, and how her family’s experience—including the loss of her father while awaiting a clinical trial—fuels the urgency behind expanding access and speeding innovation.

We also break down the foundation’s three core pillars:

Access – Helping patients overcome financial barriers to treatment
Research – Supporting clinical trials and accelerating innovation
Education – Raising awareness about available therapies and opportunities

This episode is a powerful look at how philanthropy, innovation, and patient-centered care come together to change lives—and save them.

Chapters
00:00 Introduction to The Foundation for Medical Advancement and Breakthroughs (FMAB)
00:52 Meet Afton DeVos & Her Background
03:46 How the Foundation Started 
05:24 What the Foundation Does 
05:30 Barriers to Care
08:44 Foundation Pillars: Access, Research, Education
09:36 Research: Why Faster Innovation Matters
10:07 Investigator-Initiated Trials Explained
11:45 Why Speed Matters in Clinical Research
12:01 Afton’s Personal Story & Family Cancer Journey
15:17 Funding the Foundation & Early Growth
18:22 Impact of Patient & Family Donations
20:07 Afton’s Shares More of Her Personal and Family Story
24:41 Pancreatic Cancer & Clinical Trial Access
26:11 Looking Ahead: 2026 Initiatives & Events
27:56 How to Get Involved & Support the Foundation
29:15 Final Thoughts on Access & Impact

Connect with the hosts on LinkedIn
Dr. Brandon Mancini
Christine VanTimmeren

Connect with BAMF Health
Our Website
Our Podcast

Welcome to the BAMF Health Podcast, where we explore the future of theranostics, precision medicine, and personalized healthcare.

In this episode, Christine VanTimmeren is joined by BAMF Health Founder & CEO Anthony Chang and Dr. Adnan Munkarah, President of Clinical Enterprise and Chief Physician Executive at Henry Ford Health, to discuss a major milestone: the groundbreaking of a new comprehensive theranostics center in downtown Detroit.

This conversation dives into the strategic partnership between BAMF Health and Henry Ford Health, why Detroit was selected as BAMF’s second location, and how this new center will expand access to cutting-edge theranostics care across Michigan, the Midwest, and beyond.

We explore the infrastructure and workforce challenges facing theranostics, the importance of vertical integration in radiopharmaceuticals, and how this collaboration will help train the next generation of clinicians, scientists, and healthcare professionals. Most importantly, we discuss what this means for patients—bringing earlier detection, more personalized treatment, and new hope to those who need it most.

This episode highlights how partnerships like this are not just building facilities—but building the future of medicine.

00:00 Introduction & Groundbreaking Announcement
 00:40 Why Detroit Was Chosen for BAMF’s Expansion
 02:08 Henry Ford Health’s Commitment to Detroit
 03:45 Why Henry Ford Is the Right Partner
 05:26 Why Henry Ford Chose BAMF
 09:35 Barriers to Expanding Theranostics
 10:05 Infrastructure Challenges 
 12:51 Access Challenges & Vertical Integration
 14:44 Detroit as a Healthcare Innovation Hub
 16:22 Michigan as a Leader in Precision Medicine
 18:08 Transforming the Site & Community Impact
 19:41 Workforce & Training the Next Generation
 20:34 Building the Future Healthcare Workforce
 22:17 What This Means for Patients
 24:01 The Future of Early Detection & Innovation
 25:28 Why Michigan Is Uniquely Positioned
 26:46 The Future of Healthcare in Detroit
 27:24 Final Reflections & Vision

Connect with the hosts on LinkedIn
Dr. Brandon Mancini
Christine VanTimmeren

Connect with BAMF Health
Our Website
Our Podcast

In this special World Theranostics Day episode, Christine VanTimmeren and Dr. Brandon Mancini are joined by Dr. Harshad Kulkarni, Chief Medical Advisor at BAMF Health and a global leader in theranostics, to discuss how this innovative approach is transforming cancer care and beyond.

We break down what theranostics is, how it combines diagnostics and targeted therapy, and why it represents one of the most powerful shifts toward truly personalized medicine. Dr. Kulkarni shares his global experience, insights from early adoption in Europe, and how theranostics is rapidly expanding in the United States.

We also explore the growing pipeline of clinical trials, the role of imaging in selecting the right patients, and how this approach is improving patient outcomes, quality of life, and survival. Finally, we look ahead to the future—where theranostics could extend beyond cancer into diseases like cardiovascular disease, Parkinson's, and more.

00:00 Intro & World Theranostics Day
 00:41 What Theranostics Means
 02:19 Meet Dr. Harshad Kulkarni
 02:54 How Dr. Kulkarni Entered Theranostics
 04:20 How Europe Advanced Theranostics Earlier Than the U.S.
 08:12 Why Imaging Is Essential to Theranostics
 09:59 “See What You Treat, Treat What You See”
 12:30 FDA-Approved Theranostics Today
 15:59 Beyond Cancer: Alzheimer’s, Cardiology, and More
 17:43 Why Theranostics Isn’t Available for Every Cancer Yet
 21:46 Real Patient Outcomes & Quality of Life
 25:34 What’s Next for Theranostics
 27:11 Closing Thoughts & Learn More

Connect with the hosts on LinkedIn
Dr. Brandon Mancini
Christine VanTimmeren

Connect with BAMF Health
Our Website
Our Podcast

Hosts Dr. Brandon Mancini (Medical Director at BAMF Health) and Christine VanTimmeren (Marketing Manager) introduce listeners to the groundbreaking field of Theranostics, a form of precision medicine that combines advanced imaging with targeted radiopharmaceutical therapies to diagnose and treat disease.

To kick off the series, they are joined by Chad Bassett, co-founder and COO of BAMF Health. Chad shares the origin story of the organization, including how a chance meeting with founder Anthony Chang led to a bold vision: building the world’s most advanced Theranostics center.

In this episode, you’ll hear about:

• The meaning behind the name BAMF Health 
• Why Theranostics is emerging as the next major pillar of cancer care
• How BAMF Health was designed to integrate radiopharmaceutical production, imaging, and therapy in one place
• The role of clinical trials in bringing new treatments to patients faster
• The patient-centered philosophy that guides every aspect of care
• The future of Theranostics in treating cancer, chronic pain, Alzheimer’s disease, and more

0:00 – Welcome to the BAMF Health Podcast
 0:25 – Meet the Hosts: Dr. Brandon Mancini & Christine VanTimmeren
 2:19 – What is Theranostics? The Science Behind BAMF Health
 4:24 – Why We Started the Podcast
 6:16 – Introducing Our Guest: BAMF Health Co-Founder Chad Bassett
 7:29 – The Origin Story of BAMF Health
 9:20 – Why BAMF Health Was Built as a For-Profit Company
 12:18 – Treating the First Patients and Early Growth
 14:10 – What Makes the Patient Experience Different at BAMF
 18:18 – The Role of “Time” in Patient Care
 20:15 – Humanizing Healthcare
 21:31 – The Future of Theranostics and Precision Medicine
 22:29 – New Frontiers: Cancer, Pain, and Alzheimer’s
 27:08 – Measuring Success: Giving Patients More Time
 27:33 – Chad Bassett’s Personal “Why”
 30:01 – Closing Thoughts

Connect with the hosts on LinkedIn
Brandon: https://www.linkedin.com/in/brandon-mancini-md-mba-facro-44646758/ 
Christine: https://www.linkedin.com/in/christinevt/

Connect with BAMF Health
Website: https://www.bamfhealth.com/
Our Podcast: https://www.bamfhealth.com/podcast/

Connect with the hosts on LinkedIn
Dr. Brandon Mancini
Christine VanTimmeren

Connect with BAMF Health
Our Website
Our Podcast

Welcome to The BAMF Health Podcast!

Hosts Christine VanTimmeren, BAMF Health Marketing Manager, and Dr. Brandon Mancini, board-certified radiation oncologist and Medical Director at BAMF Health, introduce the mission behind the podcast and the innovative work happening at BAMF Health.

In this episode, they explain what BAMF Health is, break down the meaning of Theranostics, and discuss how precision medicine is transforming the way diseases like cancer are diagnosed and treated. They also share what listeners can expect from future episodes, including conversations with clinicians, researchers, athletes, innovators, and healthcare leaders exploring how we can all optimize our health.

Whether you're interested in advanced cancer therapies, medical imaging, clinical trials, or the future of personalized healthcare, this podcast will explore the ideas, technologies, and people shaping the next generation of medicine.

00:00 Introduction to the BAMF Health Podcast
00:26 What is BAMF Health?
01:05 What is Theranostics?
01:49 Personalized Precision Medicine
02:34 The Future of Healthcare & Patient Empowerment
03:18 What to Expect From the Podcast
04:04 Topics We'll Cover
04:59 Episode Wrap-Up & Episode 1 Preview

Connect with the hosts on LinkedIn
Brandon: https://www.linkedin.com/in/brandon-mancini-md-mba-facro-44646758/ 
Christine: https://www.linkedin.com/in/christinevt/

Connect with BAMF Health
Website: https://www.bamfhealth.com/
Our Podcast: https://www.bamfhealth.com/podcast/

Connect with the hosts on LinkedIn
Dr. Brandon Mancini
Christine VanTimmeren

Connect with BAMF Health
Our Website
Our Podcast

Connect with the hosts on LinkedIn
Dr. Brandon Mancini
Christine VanTimmeren

Connect with BAMF Health
Our Website
Our Podcast